Ajanta Pharma (AJANTPHARM) Share Price rises 2.64% to Rs 3,385.05

Ajanta Pharma Share Price is trading at Rs 3,385.05, higher by 2.64% from the previous close of Rs 3,298. The move adds Rs 87.05 to the stock and lifts the company’s market capitalisation to Rs 41,753.18 Cr. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Ajanta Pharma Share Price Today, the rise stands out because the stock also touched the day’s high of Rs 3,385.05 after opening at Rs 3,309.50 and holding that same level as the day low.

In this Ajanta Pharma Share Price update, the move is best understood as a clear price action event rather than a story built on a disclosed trigger. The latest Univest figures show the stock moving firmly above the previous close, which keeps Ajanta Pharma Stock News focused on the numbers visible today. From here, investors tracking Ajanta Pharma Share Price Live can look at valuation, profitability and sector context to judge how the share price rise fits the broader picture.

Ajanta Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 3,385.05
Previous Close	Rs 3,298
Today's Move	Rs 87.05 (+2.64%)
Open	Rs 3,309.5
High	Rs 3,385.05
Low	Rs 3,309.5
Market Capitalisation	Rs 41,753.18 crore
Market Cap Category	Large Cap

Ajanta Pharma Ltd. (AJANTPHARM) rose to Rs 3,385.05 from the previous close of Rs 3,298, a move of Rs 87.05 or 2.64%. The stock opened at Rs 3,309.5, reached a high of Rs 3,385.05, recorded a low of Rs 3,309.5.

Ajanta Pharma Share Price moved higher in early trade and stayed at its intraday peak of Rs 3,385.05. The stock opened at Rs 3,309.50, did not print a lower level than that open, and remained above the previous close of Rs 3,298. This puts the Ajanta Pharma Share Price rise at Rs 87.05, or 2.64%, with the market capitalisation at Rs 41,753.18 Cr. For Ajanta Pharma Share Price Today, the key point is simple: the stock is trading near the upper edge of the day’s range and has not given back the gain seen so far.

That makes the Ajanta Pharma Share Price movement useful for traders following price action and for investors watching Ajanta Pharma Stock Performance alongside wider stocks in news. The move does not, by itself, establish why the stock is rising today, but it does confirm a stronger quote relative to the last session’s benchmark. For anyone checking Ajanta Pharma Share Price Update, the next analytical step is the company’s fundamental base.

Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 41,753.18 crore
P/E Ratio	36.31x
P/B Ratio	8.48x
ROE	25.42%
ROCE	32.67%
EPS	Rs 90.82
Book Value Per Share	Rs 388.77
Dividend Yield	0.85%

Ajanta Pharma Ltd. (AJANTPHARM) fundamental metrics show P/E 36.31x, P/B 8.48x, ROE 25.42%, ROCE 32.67%. Read together, these ratios describe the company's position rather than a recommendation.

Ajanta Pharma Ltd. has a market capitalisation of Rs 41,753.18 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 36.31x, P/B at 8.48x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.42% and ROCE of 32.67%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 90.82, book value per share of Rs 388.77, dividend yield of 0.85%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	36.31x
Benchmark Median P/E	31.35x
Benchmark Average P/E	46.92x
Benchmark P/E Range	3.13x to 654.72x
Company P/B Ratio	8.48x
Benchmark Median P/B	2.84x
Company ROE	25.42%
Benchmark Median ROE	11.61%
Company ROCE	32.67%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 41,753.18 crore
Benchmark Median Market Cap	Rs 827.89 crore

Ajanta Pharma Ltd. (AJANTPHARM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 36.31x, which is above the benchmark median of 31.35x, a difference of +15.82%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Ajanta Pharma Ltd. (AJANTPHARM) has a ROE of 25.42%, which is above the benchmark median of 11.61%, a difference of +118.95%. Ajanta Pharma Ltd. (AJANTPHARM) has a ROCE of 32.67%, which is above the benchmark median of 13.46%, a difference of +142.72%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,24,466.35	34.69	4.85	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,46,222.11	81.95	13.57	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,76,300.5	80.12	19.47	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,12,817.68	24.84	4.16	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,10,823.44	100.61	19.51	18.31	18.2

Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 36.31x compared with the displayed peer median of 80.12x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 25.42% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 32.67% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 41,753.18 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Ajanta Pharma

• Ajanta Pharma Share Price is higher by 2.64% today and is trading at the day’s high.
• Ajanta Pharma Share Price is supported by ROE of 25.42% and ROCE of 32.67%.
• Ajanta Pharma Share Price carries a P/E Ratio of 36.31 and a P/B Ratio of 8.48.
• Ajanta Pharma Share Price sits in the Healthcare sector and Pharmaceuticals & Drugs industry.
• Ajanta Pharma Share Price remains a notable name in Ajanta Pharma Stock News and Ajanta Pharma Share Price Today coverage.

About Ajanta Pharma

Ajanta Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of the listed pharmaceutical universe tracked on NSE and BSE, and its current market capitalisation stands at Rs 41,753.18 Cr. For readers following Ajanta Pharma Share Price, the business context matters because valuation and return ratios often reflect the market’s view of the underlying operating profile.

Ajanta Pharma Share Price discussion is also shaped by the company’s presence in a broad industry that includes large branded and specialty pharma names. In that setting, Ajanta Pharma Stock News is usually read alongside company financials, profitability ratios and peer valuation. the latest Univest figures show EPS of Rs 90.82, book value of Rs 388.77 and dividend yield of 0.85%, which together help place Ajanta Pharma Share Price within a fundamentals-first framework. Univest keeps these figures in one place so readers can connect the share price rise with company overview and stock performance.

Frequently Asked Questions

Why is Ajanta Pharma Share Price rising today?

Ans. Ajanta Pharma Share Price is rising today because it is trading Rs 87.05 above the previous close, a 2.64% gain. Univest data confirms the move itself, though no company-specific trigger has been identified.

What is Ajanta Pharma Share Price today?

Ans. Ajanta Pharma Share Price is Rs 3,385.05. The stock is higher than the previous close of Rs 3,298 and is trading at its day high in the current session.

What is Ajanta Pharma market capitalisation?

Ans. Ajanta Pharma market capitalisation stands at Rs 41,753.18 Cr. That size places the company well above the industry median in the same industry benchmark and supports broader Ajanta Pharma Stock Analysis.

How has Ajanta Pharma performed against its previous close?

Ans. Ajanta Pharma Share Price is up by Rs 87.05, or 2.64%, versus the previous close of Rs 3,298. The price opened at Rs 3,309.50 and has remained at the day’s high.

What does Ajanta Pharma Fundamental Analysis show?

Ans. Ajanta Pharma Fundamental Analysis shows a P/E Ratio of 36.31, P/B Ratio of 8.48, ROE of 25.42%, ROCE of 32.67%, EPS of Rs 90.82 and book value of Rs 388.77. Dividend yield is 0.85%.

How does Ajanta Pharma compare with Healthcare peers?

Ans. Ajanta Pharma Share Price trades on stronger return ratios than the peers listed here, with ROE of 25.42% and ROCE of 32.67%. Its P/E is below Divi’s, Torrent and Laurus, but above Zydus.

Is Ajanta Pharma expensive versus the same industry benchmark?

Ans. Ajanta Pharma Share Price is at a P/E Ratio of 36.31 versus the same-industry median of 31.35 and an average of 46.92. On P/B, it is above the median of 2.84 and the average of 4.25.

What should investors watch next in Ajanta Pharma Share News?

Ans. Investors can watch whether Ajanta Pharma Share Price holds near the day high, alongside valuation ratios, return metrics and any company-specific update that may emerge. The current move is supported by visible price action and fundamentals.

Track Ajanta Pharma Share Price on Univest

Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers tracking Ajanta Pharma Share Price can follow live share price movement, market cap, fundamental ratios and 52-week levels on Univest. The platform also brings Ajanta Pharma Stock Analysis, Ajanta Pharma Latest News and Ajanta Pharma Share Price Update together in one place so that the price rise can be viewed with valuation and sector context. For those checking Ajanta Pharma Share Price Today, Univest keeps the company profile and market insights easy to review.